Description
Recombinant monoclonal antibody to Rituximab (variable region). Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma MB2A4.
Target
Rituximab (variable region)
Target Alias Names
Rituximab, Rituxan
Isotype/Mimetic
IgG2a
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression